The Treatment Advocacy Program
The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||The Treatment Advocacy Program|
- Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative or unknown-status partners.
- Self-reported incidences of missed doses of treatment regimen.
|Study Start Date:||September 2004|
|Study Completion Date:||April 2008|
|Primary Completion Date:||May 2007 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00164333
|United States, Illinois|
|Howard Brown Medical Center|
|Chicago, Illinois, United States, 60613|
|Principal Investigator:||Dogan Eroglu, PhD.||Centers for Disease Control and Prevention|